4.2 Article

Molecular Mechanisms of MmpL3 Function and Inhibition

Journal

MICROBIAL DRUG RESISTANCE
Volume -, Issue -, Pages -

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/mdr.2021.0424

Keywords

Mycobacterium tuberculosis; MmpL3; phenotypic drug discovery

Ask authors/readers for more resources

Mycobacteria species, including pathogenic bacteria like Mycobacterium tuberculosis and Mycobacterium leprae, rely on the essential protein MmpL3 for the transport of mycolic acids and lipids. Many recent studies have explored the function, regulation, and interactions of MmpL3 as a drug target. This review provides new findings and suggests future research directions in the field.
Mycobacteria species include a large number of pathogenic organisms such as Mycobacterium tuberculosis, Mycobacterium leprae, and various non-tuberculous mycobacteria. Mycobacterial membrane protein large 3 (MmpL3) is an essential mycolic acid and lipid transporter required for growth and cell viability. In the last decade, numerous studies have characterized MmpL3 with respect to protein function, localization, regulation, and substrate/inhibitor interactions. This review summarizes new findings in the field and seeks to assess future areas of research in our rapidly expanding understanding of MmpL3 as a drug target. An atlas of known MmpL3 mutations that provide resistance to inhibitors is presented, which maps amino acid substitutions to specific structural domains of MmpL3. In addition, chemical features of distinct classes of Mmpl3 inhibitors are compared to provide insights into shared and unique features of varied MmpL3 inhibitors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available